15 mil Why? I have a guess Canuck buck on ST has suggested the $15 mil was raised as ONCY's share of the cost of Pan Can trial. The theory is that we put up $15 mil in advance and then they raise or already have the rest of the funding.
My understanding is the trial design and set of patients required are already established. In that case, we could well be in our first of two P3 trials announced as expected this fall.
As a P3 company in Pan Can, our market cap would have to be well over $1 bil.
That is the beginning of getting us to a big buyout.
So we hope anyway.